Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 129Colonic Neoplasms 54Rectal Neoplasms 48Carcinoma, Hepatocellular 29Stomach Neoplasms 23Neoplasm Metastasis 23Neoplasms 11Pancreatic Neoplasms 10Cholangiocarcinoma 9Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 7Liver Neoplasms 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Recurrence 4Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Unresectable Metastatic Colorectal Cancer 2Peritoneal Neoplasms 2Neurotoxicity Syndromes 2Neoplastic Cells, Circulating 2Intestinal Neoplasms 2Gastrointestinal Diseases 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2

Interventions

Immunotherapy 1Folfox protocol 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Rectal Cancer × Folfox protocol × Clear all
NCT03781323 2024-12-13

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

University of Rochester

Phase 2 Active not recruiting
12 enrolled 9 charts
Gastrointestinal

Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡